抄録
Food proteins and their constituent peptides can impart huge health benefits in addition to their nutritional attributes. Buckwheat
flour hydrolysate was studied for its ability to inhibit the activity of dipeptidyl peptidase-IV (DPP-IV); as shown in in-vitro assays,
inhibition of this enzyme can be used for the treatment of type II diabetes. Buckwheat flour hydrolysate prepared with Alcalase® and
Flavourzyme® showed greater DPP-IV inhibitory activity than the control sample. Buckwheat flour hydrolysate was purified using
successive column chromatography. The obtained Val–Pro–Leu (VPL) and Val–Pro–Ile (VPI) were identified using LC-Q-TOF. VPL
has been used as a commercial inhibitor of DPP-IV, named Diprotin B. VPI, with an IC50 of 18.0 ± 2.4 μM, exhibited approximately
10-fold greater inhibition of DPP-IV than VPL (200.5 ± 7.5 μM). The DPP-IV inhibitory activity of VPI was maintained at
approximately 95% after the in vitro gastrointestinal digestion process. These results suggest that the buckwheat flour hydrolysate has
potential value in functional food formulations.